Skip to main content
Erschienen in: Journal of Neurology 6/2019

15.03.2019 | Original Communication

Effect of levodopa on handwriting tasks of different complexity in Parkinson’s disease: a kinematic study

verfasst von: Poonam Zham, Dinesh Kumar, Rekha Viswanthan, Kit Wong, Kanae J. Nagao, Sridhar Poosapadi Arjunan, Sanjay Raghav, Peter Kempster

Erschienen in: Journal of Neurology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Levodopa treatment does improve Parkinson’s disease (PD) dysgraphia, but previous research is not in agreement about which aspects are most responsive. This study investigated the effect of levodopa on the kinematics of writing. Twenty-four patients with PD of less than 10 years duration and 25 age-matched controls were recruited. A practically defined off state method was used to assess the levodopa motor response, measured on the Unified Parkinson’s Disease Rating Scale Part III. The kinematic features for six handwriting tasks involving different levels of complexity were recorded from PD patients in off and on states and from the control group. Levodopa is effective for simple writing activities involving repetition of letters, denoting improved fine motor control. But the same benefit was not seen for copying a sentence and a written category fluency test, tasks that carry memory and cognitive loads. We also found significant differences in kinematic features between control participants and PD patients, for all tasks and in both on and off states. Serial testing of handwriting in patients known to be at risk for developing PD might prove to be an effective biomarker for cell loss in the substantia nigra and the associated dopamine deficiency. We recommend using a panel of writing tasks including sentence copying and memory dependence. Dual-task effects may make these activities more sensitive to early motor deficits, while their weaker levodopa responsiveness would cause them to be more stable indicators of motor progression once symptomatic treatment has been commenced.
Literatur
1.
Zurück zum Zitat Kinnier Wilson S (1925) The Croonian Lecutures on some disorders of mortility and of muscle tone, with special reference to the corpus striatum. Lancet ii:1–10 Kinnier Wilson S (1925) The Croonian Lecutures on some disorders of mortility and of muscle tone, with special reference to the corpus striatum. Lancet ii:1–10
2.
Zurück zum Zitat Shukla AW, Ounpraseuth S, Okun MS, Gray V, Schwankhaus J, Metzer WS (2012) Micrographia and related deficits in Parkinson’s disease: a cross-sectional study. BMJ Open 2(3):e000628–e000628CrossRef Shukla AW, Ounpraseuth S, Okun MS, Gray V, Schwankhaus J, Metzer WS (2012) Micrographia and related deficits in Parkinson’s disease: a cross-sectional study. BMJ Open 2(3):e000628–e000628CrossRef
4.
Zurück zum Zitat San Luciano M, Wang C, Ortega RA, Yu Q, Boschung S, Soto-Valencia J, Bressman SB, Lipton RB, Pullman S, Saunders-Pullman R (2016) Digitized spiral drawing: a possible biomarker for early Parkinson’s disease. PloS One 11(10):e0162799CrossRef San Luciano M, Wang C, Ortega RA, Yu Q, Boschung S, Soto-Valencia J, Bressman SB, Lipton RB, Pullman S, Saunders-Pullman R (2016) Digitized spiral drawing: a possible biomarker for early Parkinson’s disease. PloS One 11(10):e0162799CrossRef
5.
Zurück zum Zitat Pereira CR, Pereira DR, da Silva FA, Hook C, Weber SA, Pereira LA, Papa JP (2015) A step towards the automated diagnosis of Parkinson’s disease: analyzing handwriting movements. In: 2015 IEEE 28th international symposium on computer-based medical systems. pp 171–176 Pereira CR, Pereira DR, da Silva FA, Hook C, Weber SA, Pereira LA, Papa JP (2015) A step towards the automated diagnosis of Parkinson’s disease: analyzing handwriting movements. In: 2015 IEEE 28th international symposium on computer-based medical systems. pp 171–176
7.
Zurück zum Zitat Zham PZ, Kumar DK, Dabnichki P, Arjunan S, Raghav S (2017) Distinguishing different stages of Parkinson’s disease using composite index of speed and pen-pressure of sketching a spiral. Front Neurol 8:435CrossRef Zham PZ, Kumar DK, Dabnichki P, Arjunan S, Raghav S (2017) Distinguishing different stages of Parkinson’s disease using composite index of speed and pen-pressure of sketching a spiral. Front Neurol 8:435CrossRef
8.
Zurück zum Zitat Cobbah W, Fairhurst MC (2000) Computer analysis of handwriting dynamics during dopamimetic tests in Parkinson’s disease. In: Euromicro Conference, 2000. Proceedings of the 26th IEEE, pp 414–418 Cobbah W, Fairhurst MC (2000) Computer analysis of handwriting dynamics during dopamimetic tests in Parkinson’s disease. In: Euromicro Conference, 2000. Proceedings of the 26th IEEE, pp 414–418
9.
Zurück zum Zitat Eichhorn T, Gasser T, Mai N, Marquardt C, Arnold G, Schwarz J, Oertel W (1996) Computational analysis of open loop handwriting movements in Parkinson’s disease: a rapid method to detect dopamimetic effects. Mov Disord 11(3):289–297CrossRef Eichhorn T, Gasser T, Mai N, Marquardt C, Arnold G, Schwarz J, Oertel W (1996) Computational analysis of open loop handwriting movements in Parkinson’s disease: a rapid method to detect dopamimetic effects. Mov Disord 11(3):289–297CrossRef
10.
Zurück zum Zitat Tucha O, Mecklinger L, Thome J, Reiter A, Alders G, Sartor H, Naumann M, Lange K (2006) Kinematic analysis of dopaminergic effects on skilled handwriting movements in Parkinson’s disease. J Neural Transm 113(5):609–623CrossRef Tucha O, Mecklinger L, Thome J, Reiter A, Alders G, Sartor H, Naumann M, Lange K (2006) Kinematic analysis of dopaminergic effects on skilled handwriting movements in Parkinson’s disease. J Neural Transm 113(5):609–623CrossRef
11.
Zurück zum Zitat Poluha P, Teulings H-L, Brookshire R (1998) Handwriting and speech changes across the levodopa cycle in Parkinson’s disease. Acta Psychol 100(1):71–84CrossRef Poluha P, Teulings H-L, Brookshire R (1998) Handwriting and speech changes across the levodopa cycle in Parkinson’s disease. Acta Psychol 100(1):71–84CrossRef
13.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181–184CrossRef
14.
Zurück zum Zitat Kempster PA, O’Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson’s disease: a clinico-pathological study. Brain 133(6):1755–1762CrossRef Kempster PA, O’Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson’s disease: a clinico-pathological study. Brain 133(6):1755–1762CrossRef
15.
Zurück zum Zitat Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170CrossRef Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170CrossRef
16.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699CrossRef Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699CrossRef
17.
Zurück zum Zitat Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRef Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653CrossRef
18.
Zurück zum Zitat Zham P, Arjunan S, Raghav S, Kumar DK (2017) Efficacy of guided spiral drawing in the classification of Parkinson’s Disease. IEEE J Biomed Health Inform 22(5):1648–1652CrossRef Zham P, Arjunan S, Raghav S, Kumar DK (2017) Efficacy of guided spiral drawing in the classification of Parkinson’s Disease. IEEE J Biomed Health Inform 22(5):1648–1652CrossRef
19.
Zurück zum Zitat Pfeiffer HCV, Løkkegaard A, Zoetmulder M, Friberg L, Werdelin L (2014) Cognitive impairment in early-stage non-demented Parkinson’s disease patients. Acta Neurol Scand 129(5):307–318CrossRef Pfeiffer HCV, Løkkegaard A, Zoetmulder M, Friberg L, Werdelin L (2014) Cognitive impairment in early-stage non-demented Parkinson’s disease patients. Acta Neurol Scand 129(5):307–318CrossRef
20.
Zurück zum Zitat Thomassen AJ, Teulings H-L (1983) Constancy in stationary and progressive handwriting. Acta Physiol (Oxf) 54(1–3):179–196 Thomassen AJ, Teulings H-L (1983) Constancy in stationary and progressive handwriting. Acta Physiol (Oxf) 54(1–3):179–196
21.
Zurück zum Zitat Ma H-I, Hwang W-J, Chang S-H, Wang T-Y (2013) Progressive micrographia shown in horizontal, but not vertical, writing in Parkinson’s disease. Behav Neurol 27(2):169–174CrossRef Ma H-I, Hwang W-J, Chang S-H, Wang T-Y (2013) Progressive micrographia shown in horizontal, but not vertical, writing in Parkinson’s disease. Behav Neurol 27(2):169–174CrossRef
22.
Zurück zum Zitat du Prel J-B, Röhrig B, Hommel G, Blettner M (2010) Choosing statistical tests: part 12 of a series on evaluation of scientific publications. Dtsch Ärztebl Int 107(19):343PubMedPubMedCentral du Prel J-B, Röhrig B, Hommel G, Blettner M (2010) Choosing statistical tests: part 12 of a series on evaluation of scientific publications. Dtsch Ärztebl Int 107(19):343PubMedPubMedCentral
23.
Zurück zum Zitat Fritz CO, Morris PE, Richler JJ (2012) Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen 141(1):2CrossRef Fritz CO, Morris PE, Richler JJ (2012) Effect size estimates: current use, calculations, and interpretation. J Exp Psychol Gen 141(1):2CrossRef
24.
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Association, ArlingtonCrossRef American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Association, ArlingtonCrossRef
25.
Zurück zum Zitat Lewis FM, Lapointe LL, Murdoch BE, Chenery HJ (1998) Language impairment in Parkinson’s disease. Aphasiology 12(3):193–206CrossRef Lewis FM, Lapointe LL, Murdoch BE, Chenery HJ (1998) Language impairment in Parkinson’s disease. Aphasiology 12(3):193–206CrossRef
26.
Zurück zum Zitat Zham P, Arjunan S, Raghav S, Kumar DK (2017) Efficacy of guided spiral drawing in the classification of Parkinson’s Disease. IEEE J Biomed Health Inform 22(5):1648–1652CrossRef Zham P, Arjunan S, Raghav S, Kumar DK (2017) Efficacy of guided spiral drawing in the classification of Parkinson’s Disease. IEEE J Biomed Health Inform 22(5):1648–1652CrossRef
27.
Zurück zum Zitat Rosenblum S, Samuel M, Zlotnik S, Erikh I, Schlesinger I (2013) Handwriting as an objective tool for Parkinson’s disease diagnosis. J Neurol 260(9):2357–2361CrossRef Rosenblum S, Samuel M, Zlotnik S, Erikh I, Schlesinger I (2013) Handwriting as an objective tool for Parkinson’s disease diagnosis. J Neurol 260(9):2357–2361CrossRef
28.
Zurück zum Zitat Marsden C (1982) The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology 32(5):514–539CrossRef Marsden C (1982) The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology 32(5):514–539CrossRef
29.
Zurück zum Zitat Schwab RS, England AC, Peterson E (1959) Akinesia in Parkinson’s disease. Neurology 9(1):65–65CrossRef Schwab RS, England AC, Peterson E (1959) Akinesia in Parkinson’s disease. Neurology 9(1):65–65CrossRef
30.
Zurück zum Zitat Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA (2010) Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nat Rev Neurosci 11(11):760CrossRef Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, Agid Y, DeLong MR, Obeso JA (2010) Goal-directed and habitual control in the basal ganglia: implications for Parkinson’s disease. Nat Rev Neurosci 11(11):760CrossRef
31.
Zurück zum Zitat Maillet A, Krainik A, Debû B, Troprès I, Lagrange C, Thobois S, Pollak P, Pinto S (2012) Levodopa effects on hand and speech movements in patients with Parkinson’s disease: a FMRI study. PLoS One 7(10):e46541CrossRef Maillet A, Krainik A, Debû B, Troprès I, Lagrange C, Thobois S, Pollak P, Pinto S (2012) Levodopa effects on hand and speech movements in patients with Parkinson’s disease: a FMRI study. PLoS One 7(10):e46541CrossRef
32.
Zurück zum Zitat Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S (1999) Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol 11(3):131–137CrossRef Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S (1999) Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol 11(3):131–137CrossRef
33.
Zurück zum Zitat Rusz J, Čmejla R, Růžičková H, Klempíř J, Majerová V, Picmausová J, Roth J, Růžička E (2011) Acoustic assessment of voice and speech disorders in Parkinson’s disease through quick vocal test. Mov Disord 26(10):1951–1952CrossRef Rusz J, Čmejla R, Růžičková H, Klempíř J, Majerová V, Picmausová J, Roth J, Růžička E (2011) Acoustic assessment of voice and speech disorders in Parkinson’s disease through quick vocal test. Mov Disord 26(10):1951–1952CrossRef
34.
Zurück zum Zitat De Letter M, Santens P, Van Borsel J (2005) The effects of levodopa on word intelligibility in Parkinson’s disease. J Commun Disord 38(3):187–196CrossRef De Letter M, Santens P, Van Borsel J (2005) The effects of levodopa on word intelligibility in Parkinson’s disease. J Commun Disord 38(3):187–196CrossRef
35.
Zurück zum Zitat Ricciardi L, Bloem BR, Snijders AH, Daniele A, Quaranta D, Bentivoglio AR, Fasano A (2014) Freezing of gait in Parkinson’s disease: the paradoxical interplay between gait and cognition. Parkinsonism Relat Disord 20(8):824–829CrossRef Ricciardi L, Bloem BR, Snijders AH, Daniele A, Quaranta D, Bentivoglio AR, Fasano A (2014) Freezing of gait in Parkinson’s disease: the paradoxical interplay between gait and cognition. Parkinsonism Relat Disord 20(8):824–829CrossRef
Metadaten
Titel
Effect of levodopa on handwriting tasks of different complexity in Parkinson’s disease: a kinematic study
verfasst von
Poonam Zham
Dinesh Kumar
Rekha Viswanthan
Kit Wong
Kanae J. Nagao
Sridhar Poosapadi Arjunan
Sanjay Raghav
Peter Kempster
Publikationsdatum
15.03.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 6/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09268-2

Weitere Artikel der Ausgabe 6/2019

Journal of Neurology 6/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.